Daxor
6 hedge funds and large institutions have $1.03M invested in Daxor in 2021 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 6 → 6 (0)
0.95% less ownership
Funds ownership: 3.21% → 2.26% (-0.95%)
32% less capital invested
Capital invested by funds: $1.51M → $1.03M (-$483K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$4.74K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$407K |
| 2 |
Renaissance Technologies
New York
|
-$17.6K |
DXR Hedge Fund Activity: Q4 2021 in Review
6 of the 6,519 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q4 2021, worth a combined $1.03M — down 32% from $1.51M a quarter earlier.
Fund positioning in DXR was balanced in Q4 2021: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was UBS Group, adding an estimated $4.74K. The largest seller was Sabby Management, cutting an estimated $407K.
- 6 institutional investors held Daxor (DXR) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $1.03M of Daxor stock for Q4 2021, down 32% quarter-over-quarter.
- 0 funds opened new Daxor positions in Q4 2021 and 0 closed out.
- The largest Daxor buyer in Q4 2021 was UBS Group, an estimated $4.74K added.
- The largest Daxor seller in Q4 2021 was Sabby Management, an estimated $407K sold.
Based on aggregated 13F filings for Q4 2021.